Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitor

BACKGROUND: Dotinurad, a novel selective urate reabsorption inhibitor, exerts a serum uric acid-lowering effect by selectively inhibiting urate transporter 1 (URAT1) in patients with hyperuricemia. It is generally known that the progression of renal dysfunction is associated with a reduction in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukase, Hiroyuki, Okui, Daisuke, Sasaki, Tomomitsu, Fushimi, Masahiko, Ohashi, Tetsuo, Hosoya, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066277/
https://www.ncbi.nlm.nih.gov/pubmed/31823130
http://dx.doi.org/10.1007/s10157-019-01825-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066277/
https://www.ncbi.nlm.nih.gov/pubmed/31823130
http://dx.doi.org/10.1007/s10157-019-01825-3

Ejemplares similares